Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study

Quartier, Pierre; Alexeeva, Ekaterina; Constantin, Tamas; Chasnyk, Vyacheslav; Wulffraat, Nico; Palmblad, Karin; Wouters, Carine; Brunner, Hermine; Marzan, Katherine; Schneider, Rayfel; Horneff, Gerd; Martini, Alberto; Anton, Jordi; Wei, Xiaoling; Slade, Alan; Ruperto, Nicolino; Abrams, Özgür

doi:10.1002/art.41488

Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study

Atıf İçin Kopyala

Quartier P., Alexeeva E., Constantin T., Chasnyk V., Wulffraat N., Palmblad K., ...Daha Fazla

ARTHRITIS & RHEUMATOLOGY, 2020 (SCI İndekslerine Giren Dergi)

Cilt numarası:
Basım Tarihi: 2020
Doi Numarası: 10.1002/art.41488
Dergi Adı: ARTHRITIS & RHEUMATOLOGY

Özet

Objective To evaluate the efficacy and safety of 2 canakinumab monotherapy tapering regimens in order to maintain complete clinical remission in children with systemic juvenile idiopathic arthritis (JIA).